With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma||Dana-Farber Cancer Institute / Cigall Kadoch, PhD||'A' Award Grants||2017||Massachusetts|
|Novel Approaches to AML Differentiation Therapy||Dana-Farber Cancer Institute / Andrew Lane, MD/PhD||'A' Award Grants||2017||Massachusetts|
|Genomics of Pediatric Germ Cell Tumors||Regents of the University of Michigan / Jenny Poynter, MPH||Epidemiology Grants||2017||Michigan|
|Maternal Comorbidities, Pharmaceutical Use and Childhood Cancers: A Record Linkage Study in Taiwan||University of California, Los Angeles / Julia Heck, PhD||Epidemiology Grants||2017||California|
|Targeting BRD9 in Sarcoma||Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD||Innovation Grants||2017||Massachusetts|
|Targeting Pediatric Brain Tumors Using PTPmu Nanochains with Radiofrequency-Releasable Therapeutics||Case Western Reserve University / Susann Brady-Kalnay, PhD & Efstathios Karathanasis, PhD||Innovation Grants||2017||Ohio|
|Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-Free DNA||University of Chicago / Susan Cohn, MD & Chuan He PhD||Innovation Grants||2017||Illinois|
|Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival||Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD||Innovation Grants||2017||Ohio|
|Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers||University of California at Santa Cruz / Seth Rubin, PhD||Innovation Grants||2017||California|
|Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification||Children's Hospital of Philadelphia / Sharon Diskin, PhD||Innovation Grants||2017||Pennsylvania|